control group:placebo-controlled

2 trials

Sponsors

HenanCancerHospital, Union hospital of Tongji Medical College, Huazhong University of Science and Technology

Conditions

Chronic ITP (12 months)Hypertension

Phase 3

Phase III Clinical Trial of TQB3473 Tablets in the Treatment of Primary Immune Thrombocytopenia in Adults

Active, not recruitingChiCTR2500100803

HenanCancerHospitalChronic ITP (12 months)

Start: 2025-05-01Updated: 2025-04-21

Unknown Phase

A Randomized, Double-blind, Placebo-Controlled Phase I Clinical Trial of the Safety and Tolerability of a Single Administration and dose escalation of Angiotensin II Receptor Type 1 Therapeutic Antihypertensive Vaccine in Healthy Subjects (TAVAR-1)

RecruitingChiCTR2600127222

Union hospital of Tongji Medical College, Huazhong University of Science and TechnologyHypertension

Start: 2026-04-15Updated: 2026-06-29